Treatment as Prevention¨

Gregg Gonsalves took a wild, meandering path to the Ivory Tower. His route to becoming a professor at Yale started in street protests and spanned the globe. On Thursday he was honored with a prestigious MacArthur Fellowship. Gonsalves is one of this year’s MacArthur “geniuses.” The award from the John D. and Catherine T. MacArthur […]

El Grupo de Estudio de sida de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (Gesida) ha presentado este miŽrcoles su campaña ‘Hablemos de 90-90-90’, una iniciativa de comunicación basada en una serie de vídeos (con una duración inferior a 5 minutos) en los que expertos de este colectivo explican la realidad del VIH

Activist Paul Kawata talks to U.S. News about the potential to stop HIV and AIDS. When he came to Washington in 1985, Paul Kawata was a young man on fire. A new gay rights activist from Seattle, he had dedicated himself to battling a deadly threat to his community: a menacing new disease known as

Thursday is National Gay Men’s HIV/AIDS Awareness Day. This year’s theme is The Conversation About HIV Is Changing: Talk Undetectable — referring to advances in science that are preventing new HIV infections and helping people with HIV live longer and healthier lives. According to the Centers for Disease Control, Gay and bisexual men in the

B.C. researchers analyzed the hospital records of over 7,000 people living with HIV. 13% of people with HIV were readmitted to hospital within 30 days of discharge. Patients with a single healthcare provider were less likely to need readmission. Studies have found that HIV-positive people who have been readmitted to a hospital within 30 days

A record high of more than 90% of HIV-positive gay and bisexual men are achieving an undetectable viral load thanks to antiretroviral treatment UNSW researchers have recorded an “encouraging” major shift towards newer forms of prevention of HIV transmission, thanks to government-funded access programs. The researchers, from the university’s Centre for Social Research in Health

Queensland’s Health Department will close the state’s trial of HIV prevention medication PrEP 18 months earlier than planned, removing $740,000 in funding from the Queensland AIDS Council. PrEP, which stands for pre-exposure prophylaxis, is a once-daily pill that has been found to dramatically reduce the risk of HIV transmission in HIV-negative people, in conjunction with

Na He, dean of the School of Public Health at Fudan University in Shanghai and an expert on the AIDS epidemic in China, will deliver the third annual Richard V. Lee Lecture on Oct. 5. The lecture, presented by the Office of Global Health Initiatives in the School of Public Health and Health Professions, will

Jeff Taylor, incoming Co-chair of the Community Advisory Board of the amfAR Institute for HIV Cure Research, has been living with HIV for 35 years. A longtime HIV research advocate and cancer survivor, he has served on many community advisory boards, including currently the National Cancer Institute’s AIDS Malignancy Consortium and the Collaboratory of AIDS

Results of a modeling study showed that in dense urban settings with high prevalence of hepatitis C among people who inject drugs, HCV treatment-as-prevention strategies will have little impact over 10 years unless coverage is greatly expanded. “With the availability of more tolerable and eective direct-acting antivirals, HCV treatment-as-prevention strategies could substantially curtail HCV transmission